Le Lézard
Classified in: Health
Subjects: MAV, PSF, FVT

/R E P E A T -- Notice to the media - Government of Canada officials will hold a media technical briefing to update Canadians on the opioid crisis in Canada/


OTTAWA, June 18, 2018 /CNW/ - Officials from Health Canada, the Public Health Agency of Canada and the Canadian Institutes of Health Research will hold a media technical briefing on new measures to address the opioid crisis.

They will be available to answer questions from the media following their statements.

Date
June 19, 2018

Time
11:00AM (EDT)

Location
613-954-9003
Toll free: 1-866-206-0153
Access code: 8841444#

Media that register via Health Canada Media Relations e-mail before 11:00 a.m. on Tuesday can receive documents, which will be under embargo until the technical briefing.

 

SOURCE Health Canada


These press releases may also interest you

at 07:50
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 ? 8th, 2024
Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug...

at 07:35
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5...

at 07:30
Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
BioArctic AB's (publ) partner Eisai today published the preliminary global revenue for Leqembi during the first quarter 2024, in conjunction with their partner Biogen's first quarter report. In total, sales of JPY 2.83 billion were recorded in the...

at 07:25
RxLightning Celebrates Unprecedented Growth and Achieves Meaningful Medication Access Milestones
RxLightning, creator of the industry's leading platform for streamlining specialty medication access and affordability, is proud to have reached a number of meaningful milestones in the last year ? including significant increases in provider users,...

at 07:12
Chiesi Group's 2023 Revenue Surpasses ?3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
Highlights from Chiesi Group's 2023 financial report: Sales increased to over ?3 billion, up 10% compared to 2022 (+12% @CER), driven by the Rare business unit growth (65% @CER), and steady growth of all products in all its Regions24% of 2023 sales...

at 07:05
Av?sis and Harmony Health Launch Pioneering Salivary Testing Pilot for Patients with Special Healthcare Needs
Av?sis and Harmony Health have joined forces to bridge oral healthcare gaps for underserved Medicaid populations with special healthcare needs. The pilot aims to revolutionize preventive dentistry by harnessing the power of real-time salivary testing...

More news about Health...


News published on and distributed by: